GSK CEO SAYS DISCUSSIONS ARE ONGOING WITH A VARIETY OF GOVERNMENTS ON SUPPLY OF ITS ANTIBODY-BASED COVID-19 TREATMENT, SOTROVIMAB - JP MORGAN HEALTHCARE CONF